• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为抗癌化疗药物的Hh信号通路合成小分子抑制剂

Synthetic Small Molecule Inhibitors of Hh Signaling As Anti-Cancer Chemotherapeutics.

作者信息

Maschinot C A, Pace J R, Hadden M K

机构信息

Department of Pharmaceutical Sciences, University of Connecticut, 69 N Eagleville Rd, Unit 3092, Storrs, CT 06269-3092, USA.

出版信息

Curr Med Chem. 2015;22(35):4033-57. doi: 10.2174/0929867322666150827093904.

DOI:10.2174/0929867322666150827093904
PMID:26310919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5062741/
Abstract

The hedgehog (Hh) pathway is a developmental signaling pathway that is essential to the proper embryonic development of many vertebrate systems. Dysregulation of Hh signaling has been implicated as a causative factor in the development and progression of several forms of human cancer. As such, the development of small molecule inhibitors of Hh signaling as potential anti-cancer chemotherapeutics has been a major area of research interest in both academics and industry over the past ten years. Through these efforts, synthetic small molecules that target multiple components of the Hh pathway have been identified and advanced to preclinical or clinical development. The goal of this review is to provide an update on the current status of several synthetic small molecule Hh pathway inhibitors and explore the potential of several recently disclosed inhibitory scaffolds.

摘要

刺猬信号通路(Hh)是一种发育信号通路,对许多脊椎动物系统的正常胚胎发育至关重要。Hh信号失调被认为是多种人类癌症发生和进展的致病因素。因此,在过去十年中,开发作为潜在抗癌化疗药物的Hh信号小分子抑制剂一直是学术界和工业界研究的主要热点领域。通过这些努力,已经鉴定出靶向Hh通路多个组分的合成小分子,并推进到临床前或临床开发阶段。本综述的目的是提供几种合成小分子Hh通路抑制剂的最新研究进展,并探讨几种最近披露的抑制性骨架的潜力。

相似文献

1
Synthetic Small Molecule Inhibitors of Hh Signaling As Anti-Cancer Chemotherapeutics.作为抗癌化疗药物的Hh信号通路合成小分子抑制剂
Curr Med Chem. 2015;22(35):4033-57. doi: 10.2174/0929867322666150827093904.
2
Recent Advances in Developmental Signaling Pathway Inhibitors for the Treatment of Cancer.用于癌症治疗的发育信号通路抑制剂的最新进展
Curr Med Chem. 2015;22(35):4031-2. doi: 10.2174/092986732235151126193822.
3
Discovery of Hedgehog Antagonists for Cancer Therapy.用于癌症治疗的刺猬信号通路拮抗剂的发现。
Curr Med Chem. 2017;24(19):2033-2058. doi: 10.2174/0929867324666170316115500.
4
Hedgehog pathway agonism: therapeutic potential and small-molecule development.刺猬通路激动剂:治疗潜力和小分子药物研发。
ChemMedChem. 2014 Jan;9(1):27-37. doi: 10.1002/cmdc.201300358. Epub 2013 Nov 7.
5
Current Status of Hedgehog Signaling Inhibitors. Hedgehog 信号通路抑制剂的研究现状
Curr Top Med Chem. 2024;24(3):243-258. doi: 10.2174/0115680266280850231221074340.
6
Development of anticancer agents targeting the Hedgehog signaling.靶向刺猬信号通路的抗癌药物研发。
Cell Mol Life Sci. 2017 Aug;74(15):2773-2782. doi: 10.1007/s00018-017-2497-x. Epub 2017 Mar 17.
7
Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics.调控 Hippo 信号通路的策略用于新型抗癌治疗。
Eur J Med Chem. 2024 Oct 5;276:116694. doi: 10.1016/j.ejmech.2024.116694. Epub 2024 Jul 20.
8
Signal Transducer and Activator of Transcription Protein 3 (STAT3): An Update on its Direct Inhibitors as Promising Anticancer Agents.信号转导子和转录激活子蛋白 3(STAT3):直接抑制剂作为有前途的抗癌药物的最新进展。
Curr Med Chem. 2019;26(27):5165-5206. doi: 10.2174/0929867325666180719122729.
9
Hedgehog Signaling: From Basic Biology to Cancer Therapy.刺猬信号通路:从基础生物学到癌症治疗
Cell Chem Biol. 2017 Mar 16;24(3):252-280. doi: 10.1016/j.chembiol.2017.02.010. Epub 2017 Mar 9.
10
Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics. hedgehog 信号通路小分子抑制剂作为癌症治疗药物。
ChemMedChem. 2010 Apr 6;5(4):500-12. doi: 10.1002/cmdc.201000011.

引用本文的文献

1
The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways.骨髓微环境(BMM)细胞在急性髓系白血病(AML)进展中的作用:免疫检查点、代谢检查点和信号通路。
Cell Commun Signal. 2023 Sep 21;21(1):252. doi: 10.1186/s12964-023-01282-2.
2
Structure-Activity Relationship Studies of Hydantoin-Cored Ligands for Smoothened Receptor.二氢嘧啶核心类 smoothened 受体配体的构效关系研究。
ChemistryOpen. 2021 Oct;10(10):1028-1032. doi: 10.1002/open.202100216.
3
Formulation and evaluation of itraconazole liposomes for Hedgehog pathway inhibition.伊曲康唑脂质体的制备及评价及其对 Hedgehog 通路的抑制作用。
J Liposome Res. 2020 Sep;30(3):305-311. doi: 10.1080/08982104.2019.1668011. Epub 2019 Oct 2.
4
A structurally guided dissection-then-evolution strategy for ligand optimization of smoothened receptor.一种用于平滑受体配体优化的结构导向的先剖析后进化策略。
Medchemcomm. 2017 Apr 28;8(6):1332-1336. doi: 10.1039/c7md00104e. eCollection 2017 Jun 1.
5
Repurposing the Clinically Efficacious Antifungal Agent Itraconazole as an Anticancer Chemotherapeutic.将临床有效的抗真菌药物伊曲康唑重新用作抗癌化疗药物。
J Med Chem. 2016 Apr 28;59(8):3635-49. doi: 10.1021/acs.jmedchem.5b01718. Epub 2016 Apr 6.

本文引用的文献

1
Single-molecule imaging of Hedgehog pathway protein Smoothened in primary cilia reveals binding events regulated by Patched1.初级纤毛中刺猬信号通路蛋白Smoothened的单分子成像揭示了由Patched1调节的结合事件。
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8320-5. doi: 10.1073/pnas.1510094112. Epub 2015 Jun 22.
2
An in vivo chemical genetic screen identifies phosphodiesterase 4 as a pharmacological target for hedgehog signaling inhibition.一项体内化学遗传学筛选确定磷酸二酯酶4为刺猬信号通路抑制的药理学靶点。
Cell Rep. 2015 Apr 7;11(1):43-50. doi: 10.1016/j.celrep.2015.03.001. Epub 2015 Mar 26.
3
De novo branching cascades for structural and functional diversity in small molecules.小分子结构和功能多样性的从头分支级联。
Nat Commun. 2015 Mar 18;6:6516. doi: 10.1038/ncomms7516.
4
Smoothened variants explain the majority of drug resistance in basal cell carcinoma.平滑蛋白变体解释了基底细胞癌中大部分的耐药性。
Cancer Cell. 2015 Mar 9;27(3):342-53. doi: 10.1016/j.ccell.2015.02.002.
5
Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma.基底细胞癌中 smoothened 抑制剂耐药性的基因组分析
Cancer Cell. 2015 Mar 9;27(3):327-41. doi: 10.1016/j.ccell.2015.02.001.
6
Hedgehog inhibitors: a patent review (2013 - present).刺猬信号通路抑制剂:专利综述(2013年至今)
Expert Opin Ther Pat. 2015 May;25(5):549-65. doi: 10.1517/13543776.2015.1019864. Epub 2015 Mar 1.
7
Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer.小分子刺猬因子抑制剂与微小RNA联合递送用于治疗胰腺癌。
Mol Pharm. 2015 Apr 6;12(4):1289-98. doi: 10.1021/mp500847s. Epub 2015 Feb 25.
8
Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells.分子途径:改善癌症干细胞中刺猬信号通路治疗靶点的新方法。
Clin Cancer Res. 2015 Feb 1;21(3):505-13. doi: 10.1158/1078-0432.CCR-14-0507.
9
MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor.MRT-92通过阻断Smoothened受体跨膜结构域中的重叠结合位点来抑制Hedgehog信号通路。
FASEB J. 2015 May;29(5):1817-29. doi: 10.1096/fj.14-267849. Epub 2015 Jan 30.
10
NL-103, a novel dual-targeted inhibitor of histone deacetylases and hedgehog pathway, effectively overcomes vismodegib resistance conferred by Smo mutations.NL-103,一种新型的组蛋白去乙酰化酶和 hedgehog 通路双重靶向抑制剂,能够有效克服由 Smo 突变引起的 vismodegib 耐药性。
Pharmacol Res Perspect. 2014 Jun;2(3):e00043. doi: 10.1002/prp2.43. Epub 2014 Apr 7.